Analysis of Early Biomarkers Associated with the Development of Critical Respiratory Failure in Coronavirus Disease 2019 (COVID-19).

Krebs von den Lungen-6 biomarker coronavirus disease high-mobility group box-1 protein interleukin-6

Journal

Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402

Informations de publication

Date de publication:
28 Jan 2022
Historique:
received: 26 12 2021
revised: 18 01 2022
accepted: 24 01 2022
entrez: 25 2 2022
pubmed: 26 2 2022
medline: 26 2 2022
Statut: epublish

Résumé

Certain biomarkers predict death due to acute respiratory distress syndrome in COVID-19 patients. We retrospectively analyzed biomarkers associated with time to mechanical ventilation for respiratory failure due to COVID-19 (time-to-mechanical ventilation) in 135 consecutive patients in our hospital. We analyzed biomarkers that were elevated immediately (at admission) and later (3 days after admission) using Cox proportional hazards regression analysis. Independent biomarkers of time-to-mechanical ventilation were high C-reactive protein (CRP), interleukin (IL)-6, and Krebs von den Lungen-6 (KL-6) concentrations at admission and elevated CRP, high-mobility group box-1 protein (HMGB-1), and d-dimer levels and low platelets 3 days after admission. Receiver operating characteristic analysis for detecting the association between independent biomarkers associated with time-to-event in multivariate analyses and the start of mechanical ventilation revealed that these biomarkers had area under the curve values higher than 0.700. The present study suggests that CRP was the only biomarker associated with time-to-mechanical ventilation both at admission and 3 days after admission. Moreover, IL-6 (an inflammatory cytokine), HMGB-1 (a late inflammatory mediator), and KL-6 (reflecting injury and/or remodeling of type II pneumocytes) were associated with outcomes in COVID-19 as reported previously. In conclusion, increased CRP, IL-6, KL-6, HMGB-1, and d-dimer levels and decreased platelet counts were associated with the start of mechanical ventilation due to COVID-19.

Identifiants

pubmed: 35204430
pii: diagnostics12020339
doi: 10.3390/diagnostics12020339
pmc: PMC8870880
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Annu Rev Immunol. 2011;29:139-62
pubmed: 21219181
Respirology. 2006 Mar;11(2):164-8
pubmed: 16548901
J Biol Chem. 2004 Feb 27;279(9):7370-7
pubmed: 14660645
Cell Mol Immunol. 2020 Sep;17(9):992-994
pubmed: 32620787
J Cardiothorac Vasc Anesth. 2021 May;35(5):1276-1280
pubmed: 33349501
J Med Virol. 2020 Oct;92(10):2216-2220
pubmed: 32470148
Pediatr Int. 2011 Dec;53(6):910-4
pubmed: 21605280
Mol Aspects Med. 2014 Dec;40:1-116
pubmed: 25010388
JAMA Intern Med. 2020 Jul 1;180(7):934-943
pubmed: 32167524
Asian Pac J Allergy Immunol. 2020 Mar;38(1):1-9
pubmed: 32105090
Scand J Infect Dis. 2003;35(9):577-84
pubmed: 14620138
J Med Virol. 2021 Mar;93(3):1230-1232
pubmed: 33006404
Med Sci Monit. 2019 Mar 11;25:1828-1837
pubmed: 30853709
Thorax. 2003 Jan;58(1):52-7
pubmed: 12511721
Dis Markers. 2014;2014:804654
pubmed: 24723739
Cell Res. 2020 Mar;30(3):269-271
pubmed: 32020029
Mol Med. 2020 May 7;26(1):42
pubmed: 32380958
JAMA Intern Med. 2020 Aug 1;180(8):1081-1089
pubmed: 32396163
J Thromb Haemost. 2020 Jun;18(6):1324-1329
pubmed: 32306492
Biomark Med. 2020 Aug;14(12):1091-1097
pubmed: 32677844
Am J Physiol Lung Cell Mol Physiol. 2004 Jun;286(6):L1088-94
pubmed: 12959931
J Allergy Clin Immunol. 2020 Oct;146(4):799-807.e9
pubmed: 32710975
Clin Appl Thromb Hemost. 2021 Jan-Dec;27:10760296211010976
pubmed: 33926262
Respir Res. 2011 Mar 22;12:32
pubmed: 21418654
PLoS One. 2018 May 24;13(5):e0196558
pubmed: 29795561
Eur Respir J. 2004 Jan;23(1):142-5
pubmed: 14738246
Am Rev Respir Dis. 1993 Sep;148(3):637-42
pubmed: 8368634
Clin Chem Lab Med. 2020 Jun 25;58(7):1106-1115
pubmed: 32352397
Expert Rev Respir Med. 2020 Nov;14(11):1149-1163
pubmed: 32734777
Am J Respir Cell Mol Biol. 2008 Oct;39(4):440-7
pubmed: 18441281
Respir Investig. 2015 Mar;53(2):73-81
pubmed: 25745852
Am J Respir Cell Mol Biol. 2009 Dec;41(6):661-70
pubmed: 19265174
Intern Emerg Med. 2021 Sep;16(6):1541-1545
pubmed: 33453011
J Allergy Clin Immunol. 2020 Jul;146(1):128-136.e4
pubmed: 32425269
Front Med (Lausanne). 2021 May 25;8:638097
pubmed: 34113629
Pathogens. 2020 Mar 20;9(3):
pubmed: 32245083
PLoS One. 2015 Apr 10;10(4):e0119681
pubmed: 25860354
J Med Virol. 2021 Apr;93(4):2505-2512
pubmed: 33433006
Heliyon. 2020 Dec 07;6(12):e05672
pubmed: 33313438
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Nat Rev Dis Primers. 2019 Mar 14;5(1):18
pubmed: 30872586
Semin Immunol. 2018 Aug;38:40-48
pubmed: 29530410
Respir Investig. 2020 Nov;58(6):440-447
pubmed: 32863199
Respir Investig. 2012 Mar;50(1):3-13
pubmed: 22554854
Nat Med. 2020 Oct;26(10):1636-1643
pubmed: 32839624
BMJ. 2020 Sep 9;370:m3339
pubmed: 32907855
Respirology. 2020 Mar;25(3):275-280
pubmed: 31270920
Oxid Med Cell Longev. 2021 Apr 20;2021:6648199
pubmed: 33968298
Pathogens. 2020 Jun 20;9(6):
pubmed: 32575786

Auteurs

Hiroyoshi Yamada (H)

Department of Respirology and Clinical Research Center, National Hospital Organization Kyushu Medical Center, 1-8-1 Jigyohama, Chuo-ku, Fukuoka 810-0065, Japan.
Division of Respirology, Neurology and Rheumatology, Department of Internal Medicine, Kurume University School of Medicine, 67 Asahi-machi, Fukuoka 830-0011, Japan.

Masaki Okamoto (M)

Department of Respirology and Clinical Research Center, National Hospital Organization Kyushu Medical Center, 1-8-1 Jigyohama, Chuo-ku, Fukuoka 810-0065, Japan.
Division of Respirology, Neurology and Rheumatology, Department of Internal Medicine, Kurume University School of Medicine, 67 Asahi-machi, Fukuoka 830-0011, Japan.

Yoji Nagasaki (Y)

Department of Infectious Disease, National Hospital Organization Kyushu Medical Center, 1-8-1 Jigyohama, Chuo-ku, Fukuoka 810-0065, Japan.

Suzuyo Yoshio (S)

Shino-Test Corporation, 3-7-9 Kanda Surugadai, Chiyoda-ku, Tokyo 101-8410, Japan.

Takashi Nouno (T)

Department of Respirology and Clinical Research Center, National Hospital Organization Kyushu Medical Center, 1-8-1 Jigyohama, Chuo-ku, Fukuoka 810-0065, Japan.
Division of Respirology, Neurology and Rheumatology, Department of Internal Medicine, Kurume University School of Medicine, 67 Asahi-machi, Fukuoka 830-0011, Japan.

Chiyo Yano (C)

Department of Respirology and Clinical Research Center, National Hospital Organization Kyushu Medical Center, 1-8-1 Jigyohama, Chuo-ku, Fukuoka 810-0065, Japan.
Division of Respirology, Neurology and Rheumatology, Department of Internal Medicine, Kurume University School of Medicine, 67 Asahi-machi, Fukuoka 830-0011, Japan.

Tomohiro Tanaka (T)

Department of Respirology and Clinical Research Center, National Hospital Organization Kyushu Medical Center, 1-8-1 Jigyohama, Chuo-ku, Fukuoka 810-0065, Japan.
Division of Respirology, Neurology and Rheumatology, Department of Internal Medicine, Kurume University School of Medicine, 67 Asahi-machi, Fukuoka 830-0011, Japan.

Fumi Watanabe (F)

Department of Respirology and Clinical Research Center, National Hospital Organization Kyushu Medical Center, 1-8-1 Jigyohama, Chuo-ku, Fukuoka 810-0065, Japan.

Natsuko Shibata (N)

Department of Respirology and Clinical Research Center, National Hospital Organization Kyushu Medical Center, 1-8-1 Jigyohama, Chuo-ku, Fukuoka 810-0065, Japan.

Yoko Arimizu (Y)

Department of Infectious Disease, National Hospital Organization Kyushu Medical Center, 1-8-1 Jigyohama, Chuo-ku, Fukuoka 810-0065, Japan.

Yukako Fukamachi (Y)

Department of Infectious Disease, National Hospital Organization Kyushu Medical Center, 1-8-1 Jigyohama, Chuo-ku, Fukuoka 810-0065, Japan.

Yoshiaki Zaizen (Y)

Division of Respirology, Neurology and Rheumatology, Department of Internal Medicine, Kurume University School of Medicine, 67 Asahi-machi, Fukuoka 830-0011, Japan.

Naoki Hamada (N)

Research Institute for Diseases of the Chest, Graduate School of Medical Sciences, Kyushu University, 3-1 Maidashi Higashi-ku, Fukuoka 812-0054, Japan.

Atsushi Kawaguchi (A)

Education and Research Center for Community Medicine, Faculty of Medicine, Saga University, Saga 849-8501, Japan.

Tomoaki Hoshino (T)

Division of Respirology, Neurology and Rheumatology, Department of Internal Medicine, Kurume University School of Medicine, 67 Asahi-machi, Fukuoka 830-0011, Japan.

Shigeki Morita (S)

Department of Cardiovascular Surgery, National Hospital Organization Kyushu Medical Center, 1-8-1 Jigyohama, Chuo-ku, Fukuoka 810-0065, Japan.

Classifications MeSH